Beyond providing unmatched clinical care at Boston Children's, we're working around the clock to design approaches that let kids be kids.

The Boston Childrens Hospital Laboratory for Molecular Pediatric Pathology (BCH LaMPP) provides highly innovative tissue-based diagnostic testing, uniquely tailored to serve pediatric patients, particularly those with cancer and developmental anomalies associated with tumor-like tissue overgrowths. The core technologies of the laboratory are focused on solid-state high-throughput genomic sequencing, rare mutation detection and copy number analysis.